Abstract Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on the risk of developing subsequent disease after an excisional procedure for cervical intraepithelial neoplasia or diagnosis of genital warts, vulvar intraepithelial neoplasia, or vaginal intraepithelial neoplasia. Design Retrospective analysis of data from two international, double blind, placebo controlled, randomised efficacy trials of quadrivalent HPV […]
Bioethicists Not So Ethical When It Comes to Gardasil Injuries
Dr. Caplan et al., we are not willing to gamble with patient’s lives….. However, you and some of your associates are apparently willing to do just that. By Leslie Carol Botha, Vice-President Public Relations Janny Stokvis – Researcher and VAERS Analyst September 18, 2011 Time to get this story straight: – University of […]
Developing an HPV vaccine to prevent cervical cancer and genital warts
Bryan JT Source Vaccine and Biologics Research, Merck Research Laboratories, Merck & Co., Inc., West Point, PA, United States. janine_bryan@merck.com Abstract The challenges of the journey from target identification through development of a prophylactic quadrivalent human papillomavirus (HPV) vaccine have been met in Gardasil. Cervical cancer is the second leading cause of cancer-related death in […]
Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries
Wong CA, Saraiya M, Hariri S, Eckert L, Howlett RI, Markowitz LE, Brotherton JM, Sinka K, Martinez-Montañez OG, Kjaer SK, Dunne EF. Source: Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA. Abstract In this review, we describe plans to monitor the impact of human papillomavirus (HPV) vaccine on […]
Demyelinating disease and vaccination of the human papillomavirus
[Article in Spanish] Alvarez-Soria MJ, Hernandez-Gonzalez A, Carrasco-Garcia de Leon S, Del Real-Francia MA, Gallardo-Alcaniz MJ, Lopez-Gomez JL. Source Hospital General de Ciudad Real, Ciudad Real, Espana. Abstract INTRODUCTION. Primary prevention by prophylactic vaccination against the major cause of cervical cancer, the carcinogenic human papillomavirus (HPV) types 16 and 18, is now available worldwide. Postlicensure […]
- « Previous Page
- 1
- …
- 8
- 9
- 10
- 11
- 12
- …
- 21
- Next Page »